Comparative effectiveness of mRNA-1273 and BNT162b2 COVID-19 vaccines in immunocompromised individuals: a systematic review and meta-analysis using the …

X Wang, K Haeussler, A Spellman, LE Phillips… - Frontiers in …, 2023 - frontiersin.org
Introduction Despite representing only 3% of the US population, immunocompromised (IC)
individuals account for nearly half of the COVID-19 breakthrough hospitalizations. IC …

Update on COVID-19 therapeutics for solid organ transplant recipients, including the omicron surge

RK Avery - Transplantation, 2022 - journals.lww.com
Major changes have occurred in therapeutics for coronavirus-19 (COVID-19) infection over
the past 12–18 mo, most notably in early outpatient therapy. In most cases, solid organ …

[HTML][HTML] Effectiveness of first, second, and third COVID-19 vaccine doses in solid organ transplant recipients: a population-based cohort study from Canada

KL Naylor, SJ Kim, G Smith, E McArthur… - American Journal of …, 2022 - Elsevier
Limited data exists on the effectiveness of a third COVID-19 vaccine dose in solid organ
transplant recipients. We conducted a population-based cohort study using linked …

Immune responses to SARS-CoV-2 in dialysis and kidney transplantation

C Cantarelli, A Angeletti, L Perin, LS Russo… - Clinical Kidney …, 2022 - academic.oup.com
Despite progressive improvements in the management of patients with coronavirus disease
2019 (COVID-19), individuals with end-stage kidney disease (ESKD) are still at high risk of …

Immune response to COVID-19 mRNA vaccination in previous nonresponder kidney transplant recipients after short-term withdrawal of mycophenolic acid 1 and 3 …

T Kühn, C Speer, C Morath, M Bartenschlager… - …, 2023 - journals.lww.com
Background. The impaired immune response to coronavirus disease 2019 (COVID-19)
vaccination in kidney transplant recipients (KTRs) leads to an urgent need for adapted …

[HTML][HTML] European society of clinical microbiology and infectious diseases guidelines for coronavirus disease 2019: an update on treatment of patients with mild …

M Bartoletti, O Azap, A Barac, L Bussini… - Clinical Microbiology …, 2022 - Elsevier
Scope Despite the large availability of vaccines, coronavirus disease 2019 (COVID-19),
induced by severe acute respiratory syndrome coronavirus 2, continues to be a major threat …

[HTML][HTML] Efficacy and safety of COVID-19 vaccination in solid organ transplant recipients: A systematic review and network meta-analysis

DG Rayner, JT Nunes, D Gou, AWL Chu, SC Dai… - American Journal of …, 2024 - Elsevier
The impact of COVID-19 vaccination on clinical outcomes in solid organ transplant (SOT)
recipients remains unclear. This systematic review and network meta-analysis (NMA) sought …

Executive summary of the consensus statement of the group for the study of infection in transplantation and other immunocompromised host (GESITRA-IC) of the …

S Herrera, JM Aguado, FJ Candel, E Cordero… - Transplantation …, 2023 - Elsevier
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) arose in December 2019
in China rapidly evolving to the Coronavirus Disease 2019 (COVID-19) pandemic. Since …

Humoral and cellular immune response and the safety of third SARS-CoV-2 mRNA vaccine with longer interval after the second vaccination in kidney transplant …

S Takai, H Nishida, H Ito, H Fukuhara… - Frontiers in …, 2022 - frontiersin.org
We evaluated the humoral and cellular immune responses and safety of the third severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mRNA vaccine with a longer …

Issues regarding COVID-19 in kidney transplantation in the ERA of the Omicron variant: a commentary by the ERA Descartes Working Group

I Gandolfini, M Crespo, R Hellemans… - Nephrology Dialysis …, 2022 - academic.oup.com
The Omicron variant, which has become the dominant strain of severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) worldwide, brings new challenges to preventing and …